Bénédicte Delcoigne

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: RHEUMATOLOGY. 2023;62(10):3391-3399

Glucocorticoid exposure and the risk of serious infections in rheumatoid arthritis: a marginal structural model application.

Barbulescu A; Sjölander A; Delcoigne B; Askling J; Frisell T
Article: EUROPEAN JOURNAL OF INTERNAL MEDICINE. 2023;115:55-61

How does current disease activity in rheumatoid arthritis affect the short-term risk of acute coronary syndrome? A clinical register based study from Sweden and Norway.

Delcoigne B; Provan SA; Kristianslund EK; Askling J; Ljung L
Article: ANNALS OF THE RHEUMATIC DISEASES. 2023;82(5):601-610

Safety of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis as used in clinical practice: results from the ARTIS programme.

Frisell T; Bower H; Morin M; Baecklund E; Di Giuseppe D; Delcoigne B; Feltelius N; Forsblad-d'Elia H; Lindqvist E; Lindström U; Askling J; ARTIS Study group
Article: ACR OPEN RHEUMATOLOGY. 2023;5(5):277-284

Risk of Psychiatric Disorders in Juvenile Idiopathic Arthritis: Population- and Sibling-Controlled Cohort and Cross-Sectional Analyses.

Delcoigne B; Horne A; Reutfors J; Askling J
Article: EUROPEAN UROLOGY. 2023;83(4):343-351

A Healthy Lifestyle in Men at Increased Genetic Risk for Prostate Cancer.

Plym A; Zhang Y; Stopsack KH; Delcoigne B; Wiklund F; Haiman C; Kenfield SA; Kibel AS; Giovannucci E; Penney KL; Mucci LA
Article: RMD OPEN. 2023;9(1):e002924

Exposure to specific tumour necrosis factor inhibitors and risk of demyelinating and inflammatory neuropathy in cohorts of patients with inflammatory arthritis: a collaborative observational study across five Nordic rheumatology registers.

Delcoigne B; Kopp TI; Arkema EV; Hellgren K; Provan SA; Relas H; Aaltonen K; Trokovic N; Gudbjornsson B; Grondal G; Klami Kristianslund E; Lindhardsen J; Dreyer L; Askling J
Article: ANNALS OF THE RHEUMATIC DISEASES. 2023;82(2):189-197

Venous thromboembolism with JAK inhibitors and other immune-modulatory drugs: a Swedish comparative safety study among patients with rheumatoid arthritis.

Molander V; Bower H; Frisell T; Delcoigne B; Di Giuseppe D; Askling J; ARTIS study group
Article: RMD OPEN. 2022;8(2):e002776

Haematological malignancies in patients with psoriatic arthritis overall and treated with TNF inhibitors: a Nordic cohort study.

Cordtz RL; Askling J; Delcoigne B; Smedby KE; Baecklund E; Ballegaard C; Isomäki P; Aaltonen K; Gudbjornsson B; Love TJ; Provan SA; Michelsen B; Sexton J; Dreyer L; Hellgren K
Article: RMD OPEN. 2022;8(2):e002700

Comorbidities and treatment patterns in early rheumatoid arthritis: a nationwide Swedish study.

Tidblad L; Westerlind H; Delcoigne B; Askling J; Saevarsdottir S
Article: RHEUMATOLOGY. 2022;61(12):4741-4751

The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondyloarthritis.

Nissen M; Delcoigne B; Di Giuseppe D; Jacobsson L; Hetland ML; Ciurea A; Nekvindova L; Iannone F; Akkoc N; Sokka-Isler T; Fagerli KM; Santos MJ; Codreanu C; Pombo-Suarez M; Rotar Z; Gudbjornsson B; van der Horst-Bruinsma I; Loft AG; Möller B; Mann H; Conti F; Yildirim Cetin G; Relas H; Michelsen B; Avila Ribeiro P; Ionescu R; Sanchez-Piedra C; Tomsic M; Geirsson ÁJ; Askling J; Glintborg B; Lindström U
Article: RHEUMATOLOGY. 2022;61(11):4286-4296

Do patient-reported measures of disease activity in rheumatoid arthritis vary between countries? Results from a Nordic collaboration.

Delcoigne B; Provan SA; Hammer HB; Di Giuseppe D; Frisell T; Glintborg B; Grondal G; Gudbjornsson B; Hetland ML; Michelsen B; Nordström D; Relas H; Askling J
Article: RHEUMATOLOGY. 2022;61(9):3596-3605

Comparison of treatment retention of originator vs biosimilar products in clinical rheumatology practice in Sweden.

Di Giuseppe D; Lindstrom U; Bower H; Delcoigne B; Frisell T; Chatzidionysiou K; Sjöwall C; Lindqvist E; Askling J
Article: ARTHRITIS RESEARCH & THERAPY. 2022;24(1):185

Does persistence to methotrexate treatment in early rheumatoid arthritis have a familial component?

Sysojev AÖ; Frisell T; Delcoigne B; Saevarsdottir S; Askling J; Westerlind H
Article: ANNALS OF THE RHEUMATIC DISEASES. 2022;81(6):789-797

Short-term, intermediate-term and long-term risks of acute coronary syndrome in cohorts of patients with RA starting biologic DMARDs: results from four Nordic countries.

Delcoigne B; Ljung L; Provan SA; Glintborg B; Hetland ML; Grøn KL; Peltomaa R; Relas H; Turesson C; Gudbjornsson B; Michelsen B; Askling J
Article: ANNALS OF THE RHEUMATIC DISEASES. 2022;81(3):433-439

Influenza outcomes in patients with inflammatory joint diseases and DMARDs: how do they compare to those of COVID-19?

Bower H; Frisell T; Di Giuseppe D; Delcoigne B; Askling J
Article: RMD OPEN. 2021;7(3):e001987

Effects of the COVID-19 pandemic on patients with inflammatory joint diseases in Sweden: from infection severity to impact on care provision.

Bower H; Frisell T; di Giuseppe D; Delcoigne B; Ahlenius G-M; Baecklund E; Chatzidionysiou K; Feltelius N; Forsblad-d'Elia H; Kastbom A; Klareskog L; Lindqvist E; Lindström U; Turesson C; Sjowall C; Askling J; ARTIS Study Group
Article: ANNALS OF THE RHEUMATIC DISEASES. 2021;80(11):1410-1418

Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaboration.

Lindström U; Di Giuseppe D; Delcoigne B; Glintborg B; Möller B; Ciurea A; Pombo-Suarez M; Sanchez-Piedra C; Eklund K; Relas H; Gudbjornsson B; Love TJ; Jones GT; Codreanu C; Ionescu R; Nekvindova L; Závada J; Atas N; Yolbas S; Fagerli KM; Michelsen B; Rotar Ž; Tomšič M; Iannone F; Santos MJ; Avila-Ribeiro P; Ørnbjerg LM; Østergaard M; Jacobsson LT; Askling J; Nissen MJ
Article: RHEUMATOLOGY. 2021;60(8):3656-3668

Risk of solid cancers overall and by subtypes in patients with psoriatic arthritis treated with TNF inhibitors - a Nordic cohort study.

Hellgren K; Ballegaard C; Delcoigne B; Cordtz R; Nordström D; Aaltonen K; Gudbjornsson B; Love TJ; Aarrestad Provan S; Sexton J; Zobbe K; Kristensen LE; Askling J; Dreyer L
Article: RHEUMATOLOGY. 2021;60(8):3760-3769

Comorbidities at diagnosis of rheumatoid arthritis: a population-based case-control study.

Tidblad L; Westerlind H; Delcoigne B; Askling J; Saevarsdottir S
Article: ANNALS OF THE RHEUMATIC DISEASES. 2021;80(8):1086-1093

Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study.

Bower H; Frisell T; Di Giuseppe D; Delcoigne B; Ahlenius G-M; Baecklund E; Chatzidionysiou K; Feltelius N; Forsblad-d'Elia H; Kastbom A; Klareskog L; Lindqvist E; Lindström U; Turesson C; Sjöwall C; Askling J; ARTIS Study Group
Article: RMD OPEN. 2020;6(2):e001363

How do we use biologics in rheumatoid arthritis patients with a history of malignancy? An assessment of treatment patterns using Scandinavian registers.

Chatzidionysiou K; Delcoigne B; Frisell T; Hetland ML; Glintborg B; Dreyer L; Cordtz R; Zobbe K; Nordström D; Trokovic N; Aaltonen K; Provan SA; Grondal G; Gudbjornsson B; Askling J
Article: RMD OPEN. 2020;6(2):e001282

Does autoimmune thyroid disease affect rheumatoid arthritis disease activity or response to methotrexate?

Waldenlind K; Delcoigne B; Saevarsdottir S; Askling J
Article: RMD OPEN. 2020;6(2):e001201

Gastrointestinal perforations in patients with rheumatoid arthritis treated with biological disease-modifying antirheumatic drugs in Sweden: a nationwide cohort study.

Barbulescu A; Delcoigne B; Askling J; Frisell T
Article: ANNALS OF THE RHEUMATIC DISEASES. 2020;79(5):566-572

Risk of neuroinflammatory events in arthritis patients treated with tumour necrosis factor alpha inhibitors: a collaborative population-based cohort study from Denmark and Sweden.

Kopp TI; Delcoigne B; Arkema EV; Jacobsen RK; Magyari M; Ibfelt EH; Locht H; Sellebjerg F; Cordtz RL; Jensen DV; Askling J; Dreyer L
Article: RMD OPEN. 2020;6(1):e001197

Siblings of patients with rheumatoid arthritis have an increased mortality rate: a Swedish cohort study.

Westerlind H; Delcoigne B; Askling J
Article: NEUROLOGY. 2020;94(11):e1201-e1212

Blood neurofilament light levels segregate treatment effects in multiple sclerosis.

Delcoigne B; Manouchehrinia A; Barro C; Benkert P; Michalak Z; Kappos L; Leppert D; Tsai JA; Plavina T; Kieseier BC; Lycke J; Alfredsson L; Kockum I; Kuhle J; Olsson T; Piehl F
Article: RMD OPEN. 2019;5(2):e001055

Juvenile idiopathic arthritis and risk of cancer before and after the introduction of biological therapies.

Horne A; Delcoigne B; Palmblad K; Askling J
Article: STATISTICAL METHODS IN MEDICAL RESEARCH. 2018;27(6):1818-1829

Feasibility of reusing time-matched controls in an overlapping cohort.

Delcoigne B; Hagenbuch N; Schelin ME; Salim A; Lindström LS; Bergh J; Czene K; Reilly M
Article: INTERNATIONAL JOURNAL OF EPIDEMIOLOGY. 2018;47(3):841-849

Valid and efficient subgroup analyses using nested case-control data.

Delcoigne B; Støer NC; Reilly M
Article: STATISTICS IN MEDICINE. 2017;36(3):455-465

Comparisons of risk prediction methods using nested case-control data.

Salim A; Delcoigne B; Villaflores K; Koh W-P; Yuan J-M; van Dam RM; Reilly M
Article: JOURNAL OF CLINICAL EPIDEMIOLOGY. 2017;82:79-86

Breaking the matching in nested case-control data offered several advantages for risk estimation.

Delcoigne B; Colzani E; Prochazka M; Gagliardi G; Hall P; Abrahamowicz M; Czene K; Reilly M
Article: PSYCHIATRIC GENETICS. 1998;8(4):197-205

European Collaborative Project on Affective Disorders: interactions between genetic and psychosocial vulnerability factors.

Souery D; Lipp O; Serretti A; Mahieu B; Rivelli SK; Cavallini C; Ackenheil M; Adolfsson R; Aschauer H; Blackwood D; Dam H; Delcoigne B; Demartelaer V; Dikeos D; Fuchshuber S; Heiden M; Jablensky A; Jakovljevic M; Kessing L; Lerer B; Macedo A; Mellerup T; Milanova V; Muir W; Mendlewicz J
Visa fler

Alla övriga publikationer

Review: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2023;32(3):279-286

Federated analyses of multiple data sources in drug safety studies.

Gedeborg R; Igl W; Svennblad B; Wilén P; Delcoigne B; Michaëlsson K; Ljung R; Feltelius N
Corrigendum: RHEUMATOLOGY. 2022;61(12):4998

Correction to: Do patient-reported measures of disease activity in rheumatoid arthritis vary between countries? Results from a Nordic collaboration.

Delcoigne B; Provan SA; Hammer HB; Di Giuseppe D; Frisell T; Glintborg B; Grondal G; Gudbjornsson B; Hetland ML; Michelsen B; Nordström D; Relas H; Askling J
Letter: ANNALS OF THE RHEUMATIC DISEASES. 2022;81(5):e74

Response to: 'Neuroinflammatory events after anti-TNFα therapy' by Kaltsonoudis et al.

Kopp TI; Delcoigne B; Arkema EV; Magyari M; Locht H; Sellebjerg FT; Cordtz RL; Jensen DV; Askling J; Dreyer L
KI thesis / dissertation: 2017

Efficient design and analysis of extended case-control studies

Delcoigne, Bénédicte

Anställningar

Statistiker, Medicin, Solna, Karolinska Institutet, 2017-

Examina och utbildning

Medicine Doktorsexamen, Institutionen för medicinsk epidemiologi och biostatistik, Karolinska Institutet, 2017

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI